Vringo’s NDA dispute with ZTE has been previously noted in this blog. The case in the Southern District of New York involved violation of a Non-Disclosure Agreement by alleging revealing confidential materials […]
Vringo’s Litigation with ZTE: The Continuing Saga…
CFDA’s New Policies to Promote IP and Innovation in the Pharma Sector
As noted previously in this blog, the death of patent linkage which had been heralded by draft Drug Registration Rules appears to be premature. In fact, the China Food and Drug Administration […]
SPC Puts National Appellate IP Court On Its Agenda
At an IP symposium held this Wednesday, May 10, 2017 in Chengdu, it was revealed by a senior Chinese academic (Prof. Wu Handong) in response to a question raised by former Chief Judge Randall […]
Fordham’s China IP Module (NYC), China IP Road Shows (Dallas and Houston) & Mandarin Intro to IP (Houston)
The USPTO in conjunction with its Dallas regional office, the United States Commercial Service and other partners is offering two seminars about protecting your IP in China and another seminar discussing IP […]
Upcoming China IP Program with the Boston Bar
The U.S. Patent and Trademark Office, Boston Bar Association and the U.S. Commercial Service for Massachusetts are bringing together thought leaders and policy makers on China IP issues from U.S. Government, academics […]
GAI’s Comments on AUCL
Ahead of schedule, George Mason University’s Global Antitrust Institute (“GAI”) has prepared its comments on the NPC’s proposed revisions to the Anti-Unfair Competition Law, available here. GAI commended the National People’s Congress for […]
Of Trade Secrets, Section 337, AUCL Reform and Evidence Production
When faced with trade secret misappropriation, the United States International Trade Commission can provide a forum for U.S. companies faced with unfair competition resulting from the misappropriation, even if the “theft” occurs […]
Upcoming Licensing Program in Taiwan
The American Institute of Taiwan (AIT) and the Taiwan Ministry of Economic Affairs, amongst others, are sponsoring a licensing program at AIT on March 30, 2017. The program will cover licensing issues […]
More Policy Discussions on Pharma IP Reform
There appear to be some serious discussion of late regarding China using its IP laws to encourage more innovative drugs. One significant advance was the recent amendments to China’s Patent Examination Guidelines […]
RIP，Dr. Richard Solomon
Dr. Richard Solomon, who worked with Dr. Henry Kissinger on normalization of relations between the United States and China passed away on March 13, 2017. The Washington Post described Solomon in its […]
China IPR - Intellectual Property Developments in China 